$country= Comparative statistics by cancer registry - SurvCan

Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site

(Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)

Click on cancer site (ICD-10 code) for comparison
SiteICD-10TotalAbsolute survival %Relative survival %ASRS% at 5-years
1-year3-year5-year1-year3-year5-yearall ages0-74 years
C00Lip16178.862.755.880.967.763.663.461.3
C01-02Tongue210656.531.225.358.334.229.327.829.7
C03-06Oral cavity276960.539.432.362.242.837.035.036.0
C09Tonsil51346.720.313.948.422.616.716.716.6
C10Other oropharynx24351.523.615.753.326.218.618.320.4
C11Nasopharynx24357.328.722.958.630.825.520.324.7
C12-13Hypopharynx190247.523.317.849.326.321.721.823.1
C15Oesophagus312836.818.913.038.321.115.413.716.2
C16Stomach220533.617.612.834.819.514.811.615.2
C18Colon157852.535.127.454.538.832.325.430.3
C19-20Rectum121759.737.228.661.941.233.626.131.1
C21Anus22062.842.334.064.846.339.532.536.9
C25Pancreas91722.915.712.523.817.414.613.215.2
C32Larynx188059.937.228.662.341.834.632.836.0
C33-34Lung345128.415.410.929.617.313.210.913.4
C50Breast729477.956.646.079.760.451.448.251.6
C53Cervix443675.253.642.276.656.646.143.846.4
C56Ovary202949.729.122.850.730.724.621.022.9
C60Penis32775.149.243.677.954.951.647.153.3
C61Prostate146364.339.324.069.650.235.928.442.3
C62Testis38369.358.053.070.059.555.255.156.2
C64Kidney81953.038.231.254.841.836.032.135.2
C67Urinary bladder130767.045.632.570.653.641.834.645.6
C81Hodgkin lymphoma52870.058.548.871.060.851.750.652.2
C82-85+C96Non-Hodgkin lymphoma233850.338.030.251.841.134.134.237.1
C91Lymphoid leukaemia109934.822.015.235.422.916.314.815.5
C92-94Myeloid leukaemia126131.220.613.731.821.514.612.815.2
C95Leukaemia unspecified34518.710.36.119.210.96.75.97.1


Graphs:


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)
- Table2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)
- Table5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Mumbai, India, 1992-1999)
- Table6: Comparison of 5-year absolute and relative survival of cases diagnosed between 1982-1986 and 1992-1999 (Mumbai, India)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)